Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Skin Quality Improvement When Hyper-Diluted OnabotulinumtoxinA (Botox®, Botox® Cosmetic /BTXa/) is Injected Into The Superficial Dermis of the Mid-Face

NCT03097835 is registered in ClinicalTrials.gov with Steve Yoelin M.D. Medical Associates, Inc. as lead sponsor.

NCT NCT03097835
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03097835 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Skin Quality Improvement When Hyper-Diluted OnabotulinumtoxinA (Botox®, Botox® Cosmetic /BTXa/) is Injected Into The Superficial Dermis of the Mid-Face
Lead sponsor
Steve Yoelin M.D. Medical Associates, Inc.
Phase
Phase 2
Overall status
Completed
Start date
February 12, 2018
Completion date
July 26, 2018
Enrollment
15 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

skin quality